US 2015/0306163 A1Published application

Prevention and treatment of disorders connected to impaired neurotransmission

AssigneeNestec S.A.

InventorsElizabeth Offord Cavin, Catherine Mace

Life of this patent

Estimating the term…

Abstract

The present invention relates to the use of rosemary extracts for the prevention and treatment of disorders connected to impaired neurotransmission such as depression in humans, companion animals and farm animals.

Claims1

Dependent claims

A method for manufacturing a composition comprising the step of using an extract of Rosmarinum officinalis to manufacture a composition selected from the group consisting of a medicament and nutritional composition.

Dependencies are inferred from the claim text.

Facts

Application: 14/710,145Filed 12 May 2015
Priority: EP 06124781.324 Nov 2006
Published: 29 Oct 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 36/53
Magnoliopsida: lamiaceae or Labiatae , e.g. thyme, rosemary or lavender
A61P 25/00
Drugs for disorders of the nervous system
A61P 25/18
Drugs for disorders of the nervous system: antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
A61P 25/24
Drugs for disorders of the nervous system: antidepressants

Family

Application12/515,653Division · filed 15 Feb 2010
Application14/710,145Division
US 2010/0233303 A1Published application
US 2015/0306163 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…